Does BIVALIRUDIN Cause Pericardial effusion? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Pericardial effusion have been filed in association with BIVALIRUDIN (BIVALIRUDIN). This represents 1.2% of all adverse event reports for BIVALIRUDIN.
10
Reports of Pericardial effusion with BIVALIRUDIN
1.2%
of all BIVALIRUDIN reports
1
Deaths
2
Hospitalizations
How Dangerous Is Pericardial effusion From BIVALIRUDIN?
Of the 10 reports, 1 (10.0%) resulted in death, 2 (20.0%) required hospitalization, and 1 (10.0%) were considered life-threatening.
Is Pericardial effusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIVALIRUDIN. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does BIVALIRUDIN Cause?
Drug ineffective (148)
Haemorrhage (79)
Off label use (73)
Thrombosis in device (63)
Vascular stent thrombosis (63)
Heparin-induced thrombocytopenia (61)
Thrombosis (61)
Coagulation time abnormal (42)
Gastrointestinal haemorrhage (40)
Coronary artery thrombosis (33)
What Other Drugs Cause Pericardial effusion?
TREPROSTINIL (584)
IBRUTINIB (467)
CYCLOPHOSPHAMIDE (458)
NIVOLUMAB (454)
METHOTREXATE (412)
MACITENTAN (407)
DASATINIB (388)
ADALIMUMAB (374)
AMBRISENTAN (371)
PEMBROLIZUMAB (362)
Which BIVALIRUDIN Alternatives Have Lower Pericardial effusion Risk?
BIVALIRUDIN vs BLEOMYCIN
BIVALIRUDIN vs BLINATUMOMAB
BIVALIRUDIN vs BLONANSERIN
BIVALIRUDIN vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1
BIVALIRUDIN vs BOCEPREVIR